LATEST TWEETS - CURATED BY HASH FINANCE
X4 Pharmaceuticals Inc $XFOR CEO Sells $86,198.16 in Stock https://t.co/BLvahKIelY
Paula Ragan Sells 4,275 Shares of X4 Pharmaceuticals Inc $XFOR Stock https://t.co/5r7j1Uv1BH
X4 Pharmaceuticals $XFOR vs. Alector $ALEC Head to Head Comparison https://t.co/rYmC3QwoFN
$XFOR https://t.co/0yjxsSh5vN X4 Pharmaceuticals Inc. The current setup estimates this equity has a negative short… https://t.co/RCNQQJV6T9
$XFOR:
New Insider Filing on X4 Pharmaceuticals, Inc's
President and CEO
PAULA RAGAN:
https://t.co/dQs8pdTbiF
$XFOR - X4 Pharmaceuticals (XFOR) Investor Presentation - Slideshow. https://t.co/lwxeDxVl8a #business #economy #stocks
$XFOR Paula Ragan Dumps 9.7K Shares of X4 Pharmaceuticals, Inc https://t.co/ZVLZ080O9b
Insider Paula Ragan reports selling 16,382 shares of $XFOR for a total cost of $143,851.41 https://t.co/iorVWrd0Fc
Rating Update for X4 Pharmaceuticals Inc ($XFOR) https://t.co/Ve9RSYwhZF
X4 Pharmaceuticals $XFOR and Alector $ALEC Head to Head Review https://t.co/SbGFqCR8oZ
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635 $XFOR https://t.co/ODl9EZPdfr
$XFOR NEW ARTICLE : X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)… https://t.co/8kzDHZoJgA
$XFOR X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
https://t.co/kn9fgbNIL0
X4 Pharmaceuticals Inc $XFOR Receives $18.00 Consensus Price Target from Brokerages https://t.co/vaVSXg95si
X4 Pharmaceuticals Earns Buy Rating from Canaccord Genuity $XFOR https://t.co/njnBXOJiqS
